About | Free Trial

Last Update

2016-03-29T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Alistair Draffan?

Dr. Alistair Draffan G.

Executive Vice President, Operations

360biolabs

Direct Phone: +61 *********       

Email: a***@***.com

360biolabs

Background Information

Employment History

Vice President, Discovery and Business Development

Innoviron Pty Ltd

Director, Drug Discovery

Biota Holdings Limited

Senior Medicinal Chemist

Celltech Group plc

Web References (6 Total References)


Biota Pharmaceuticals Incorporated: Scientific Publications & Presentations

www.biotapharma.com [cached]

"Discovery of a New Series of Pan-genotypic NS5b Inhibitors for Hepatitis C: the Indazole Amide Class of Site IV Polymerase Antivirals", presented by Dr Alistair Draffan, Director, Drug Discovery. 


Bioactive Discovery & Development Group - The Royal Australian Chemical Institute Incorporated

www.raci.org.au [cached]

Dr Alistair Draffan Director, Drug Discovery, Biota


Ausbiotech 2010 National Conference - Speakers

ausbiotech2010.com.au [cached]

Dr Alistair Draffan, Director Drug Discovery, Biota Holdings Limited


Ausbiotech 2010 National Conference - Speakers

ausbiotech2010.com.au [cached]

Dr Alistair Draffan, Director Drug Discovery, Biota Holdings Limited


Biota Holdings Limited: Scientific Publications & Presentations

www.biota.com.au [cached]

"Discovery of new orally active antivirals for the treatment of Respiratory Syncytial Virus (RSV): identification of a clinical candidate", presented by Dr Alistair Draffan, Director, Drug Discovery.

...
"Discovery of a new class of Inhibitors for Respiratory Syncytial Virus (RSV)" presented by Dr Alistair Draffan, Director, Drug Discovery. 8 October 2008: University of Adelaide, Australia.
 July 2008
"Discovery of a new class of polycyclic RSV inhibitors" presented by Dr Alistair Draffan, Director, Drug Discovery.
...
"Discovery of a new class of polycyclic RSV inhibitors" and "Preclinical development of a new class of orally active drug candidates for the treatment of RSV infections" presented by Dr Alistair Draffan, Associate Director, Medicinal Chemistry.

Similar Profiles

Other People with this Name

Other people with the name Draffan

Alex Draffan
AT&T Inc.

George Draffan
George Draffan

Susan Draffan
Santa Barbara Wellness Directory Inc

Lynda Draffan
AstraZeneca PLC

George Draffan

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory